- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
June 18th, 2007
Osmetech PLC said it has granted a non-exclusive research license to US-based Minerva Biotechnologies Corp for use of its self-assembling monolayer technology in tandem with Minerva's proprietary nanoparticle technology.
Financial terms of the deal were not disclosed.
The molecular diagnostics company said Minerva plans to use the technology for signal enhancement, drug design, drug screening, and functional proteomics.
|Related News Press|
The NanoWizardŽ AFM from JPK is applied for interdisciplinary research at the University of South Australia for applications including smart wound healing and how plants can protect themselves from toxins July 26th, 2016
Accurate design of large icosahedral protein nanocages pushes bioengineering boundaries: Scientists used computational methods to build ten large, two-component, co-assembling icosahedral protein complexes the size of small virus coats July 25th, 2016
Ultrasensitive sensor using N-doped graphene July 26th, 2016
Research team led by NUS scientists develop plastic flexible magnetic memory device: Novel technique to implant high-performance magnetic memory chip on a flexible plastic surface without compromising performance July 21st, 2016